Aurogra 100 mg is a generic sildenafil citrate ED treatment manufactured in India that is widely distributed in many countries around the world, especially in Asia, Africa, Latin America, Eastern Europe, and parts of the Middle East, where generic medicines are commonly sold and exported.   Approval & Regulatory Status Not FDA‑approved in the United States: The U.S. Food and Drug Administration (FDA) has confirmed that products labeled as “Aurogra 100” are not approved for sale or distribution in the United States. This means it is not legally marketed as an FDA‑regulated drug there, even though sildenafil itself is approved in branded and generic forms (like Viagra) when properly authorized. Aurogra 100 mg in many global markets: Aurogra tablets are manufactured in India and exported to multiple countries including Singapore, the United Arab Emirates, Belgium, and Mauritius based on shipping/import records, indicating international distribution. Prescription requirement: In most countries where it is sold, Aurogra is a prescription‑only medication because sildenafil requires a doctor’s authorization due to safety considerations.  What This Means In countries where local drug regulatory authorities have approved it, Aurogra can be legally marketed and sold in pharmacies with a prescription. Where it hasn’t been approved (e.g., the U.S.), it may still be available through online or international pharmacies, but this is not the same as regulatory approval.